Jun 17, 2026 04:13AM
May 15, 2026 05:58AM
May 1, 2026 05:55AM
May 1, 2026 05:32AM
Apr 30, 2026 04:34PM
Apr 28, 2026 09:29AM
Apr 27, 2026 09:47AM ResMed (RMD) PT Lowered to $286 at Morgan Stanley
Apr 27, 2026 08:32AM
Apr 15, 2026 11:51AM
Apr 15, 2026 11:24AM
Mar 16, 2026 07:46AM
Jan 30, 2026 08:53AM
Jan 30, 2026 08:12AM
Jan 30, 2026 06:34AM Needham Reiterates Hold Rating on ResMed (RMD)
Jan 29, 2026 04:42PM
Jan 26, 2026 08:19AM
Jan 22, 2026 09:39AM
Dec 18, 2025 04:02AM
Dec 16, 2025 03:50AM
Dec 12, 2025 09:38AM
Dec 1, 2025 10:07AM Goldman Sachs Adjusts APAC Director's Cut Names in December Update
Nov 20, 2025 02:32PM
Nov 18, 2025 03:14PM
Oct 30, 2025 04:47PM
Oct 21, 2025 04:24AM
Sep 25, 2025 07:31AM
Sep 18, 2025 06:41AM
Sep 17, 2025 05:28AM KeyBanc Reiterates Overweight Rating on ResMed (RMD)
Sep 16, 2025 09:43AM
Aug 4, 2025 05:24AM
Aug 1, 2025 10:16AM
Aug 1, 2025 09:07AM
Aug 1, 2025 08:40AM
Aug 1, 2025 06:08AM
Jul 31, 2025 05:12PM ResMed (RMD) Tops Q4 EPS by 7c
Jul 31, 2025 04:53PM
Jul 22, 2025 05:14AM
Jul 15, 2025 03:06PM
Jul 15, 2025 06:40AM
Jun 17, 2025 07:05AM
Jun 13, 2025 08:26AM
Jun 2, 2025 05:48AM ResMed (RMD:AU) (RMD) PT Raised to AUD45 at Citi, Removes 90-Day Downside Catalyst Watch
May 20, 2025 08:49AM
Apr 24, 2025 10:22AM
Apr 24, 2025 09:21AM
Apr 24, 2025 08:28AM
Apr 24, 2025 08:17AM
Apr 24, 2025 06:59AM
Apr 24, 2025 06:34AM Oppenheimer Reiterates Perform Rating on ResMed (RMD)
Apr 23, 2025 04:53PM

404,871 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All